30JUN

Welcome To Mediterr J Med Res

Manuscripts are accepted for consideration with the understanding that they represent original material and are not being considered for publication elsewhere. The editors welcome the submission of relevant articles for editorial consideration. Manuscripts and all scientific and professional data should be addressed to Editor-in-Chief (abdulgbaj1@hotmail.com / Fmosherif@yahoo.com).

Mediterranean Journal of Medical Research
https://mrj.org.ly/article/6a3c40eda9539502f81ca992

Mediterranean Journal of Medical Research

Narrative review Pharmacology

Caffeine and cognitive performance: The social, neurocognitive, and ethical dimensions of lifestyle pharmacology

Hikmat O. Olayanju, Elizabeth E. Olawale, Precious A. Ologun, Eniola I. Oloko, Oluwafemi B. Ajiboye, Joseph S. Yunisa

Downloads: 0
Views: 11

Abstract

Caffeine is the most widely consumed psychoactive substance and remains deeply embedded within modern society. Beyond its conventional dietary role, caffeine has increasingly emerged as a major agent in the expanding field of lifestyle pharmacology, where the active substances are used not for the treatment of disease but to enhance cognition, mood, productivity, and social functioning. The growing dependence on caffeine among students reflects broader societal pressures linked to academic competition, sleep restriction, productivity culture, and the normalization of pharmacological cognitive enhancement. This narrative review aims to examine the neuropharmacological mechanisms, cognitive effects, social dimensions, public health implications, and ethical controversies surrounding caffeine use, particularly among university students and young adults. Literature was reviewed to synthesize current evidence regarding caffeine’s mechanism of action, behavioral effects, and long-term consequences. Caffeine primarily acts through competitive antagonism of Adenosine A1 and A2A receptors, thereby reducing inhibitory sleep signaling and indirectly enhancing dopaminergic and noradrenergic neurotransmission, leading to alertness, vigilance, concentration, reaction time, mood, and certain aspects of memory consolidation, particularly under conditions of fatigue and sleep deprivation. Despite these benefits, chronic caffeine consumption is associated with tolerance, adenosine receptor upregulation, physiological dependence, withdrawal syndrome, sleep disruption, anxiety, cardiovascular stimulation, and impaired recovery from cognitive fatigue. The review explores the increasing popularity of energy drinks among adolescents and university students, the influence of aggressive stimulant marketing, and the ethical concerns surrounding caffeine as a socially accepted form of cognitive enhancement or “academic doping”. Although moderate caffeine intake remains relatively safe for most healthy adults, the increasing normalization of excessive caffeine use among students and young professionals raises important neuro-ethical and public health concerns. Greater awareness regarding safe caffeine practices and informed stimulant use is necessary within academic institutions and society.

Keywords

Academic performance, adenosine receptors, cognitive enhancement, neuroethics, lifestyle

References

  1. Franke AG, Lieb K, Hildt E. What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement. PLoS One. 2012; 7(6): e40047. doi: 10.1371/journal.pone.0040047
  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing. 2013. doi: 10.1176/appi.books.9780890425596
  3. El Seifi OS, Younis FE, Alsaiari NA, Alanazi RM, Alanazi AK, Alamri LM, et al. Caffeine intake and awareness of its adverse effects: Insights from the medical students at the University of Tabuk. PLoS One. 2025; 20(10): e0335391. doi: 10.1371/journal
  4. Barone JJ, Roberts HR. Caffeine consumption. Food and Chemical Toxicology. 1996; 34(1): 119-129. doi: 10.1016/ 0278-6915(95)00093-3
  5. Biaggioni I, Paul S, Puckett A, Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists in humans. Journal of Pharmacology and Experimental Therapeutics. 1991; 258(2): 588-593. PMID: 1865359.
  6. Maslen H, Faulmüller N, Savulescu J. Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate. Frontiers in Systems Neurosciences. 2014; 8: 107. doi: 10.3389/fnsys.2014.00107
  7. Borota D, Murray E, Keceli G, Chang A, Watabe J, Ly M, Toscano J, Yassa MA. Post-study caffeine administration enhances memory consolidation in humans. Nature Neuroscience. 2014; 17(2): 201-203. doi: 10.1038/nn.3623
  8. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006; 295(10): 1135-1141. doi: 10.1001/jama.295.10.1135
  9. Diogo LN, Machado NJ, Gonçalves FQ. Caffeine, adenosine receptors, and synaptic plasticity. Journal of Alzheimer’s Disease. 2013; 34(4): 803-814. doi: 10.3233/JAD-122112
  10. Drake C, Roehrs T, Shambroom J, Roth T. Caffeine effects on sleep taken 0, 3, or 6 hours before bedtime. Journal of Clinical Sleep Medicine. 2013; 9(11): 1195-1200. doi: 10.5664/jcsm.3170
  11. Einother SJ, Giesbrecht T. Caffeine as an attention enhancer: Reviewing existing assumptions. Psychopharmacology. 2013; 225(2): 251-274. doi: 10.1007/s00213-012-2917-2
  12. Evans S, Griffiths R, Juliano L. Energy drink consumption and public health implications among young adults. Nutrients. 2023; 15(3): 455. doi: 10.3390/nu15030455
  13. Grzegorzewski J, Bartsch  F, Köller A and König M. Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing. Frontiers in Pharmacology. 2022; 12:752826. doi: 10.3389/fphar.2021.752826
  14. Ferre S. Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine. Journal of Alzheimer’s Disease. 2010; 20(s1): S35-S49. doi: 10.3233/JAD-2010-1400
  15. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews. 1999; 51(1): 83-133. PMID: 10049999.
  16. Rodak K, Kokot I, Kratz EM. Caffeine as a Factor Influencing the Functioning of the Human Body-Friend or Foe? Nutrients. 2021; 13(9): 3088. doi: 10.3390/nu13093088
  17. El-Shintiri NE, Elsharksi A, Mohamed IE, Elmabsout AA, Elathram SF, Aldressi MA, et al. Impact of energy drink consumption on pattern and quality of sleep among students in Libyan International Medical University. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(3): 24-30. doi: 10.5281/zenodo.7115154
  18. Veselska ZD, Husarova D, Kosticova M. Energy drinks consumption associated with emotional and behavioural problems via lack of sleep and skipped breakfast among adolescents. International Journal of Environmental Research and Public Health. 2021; 18(11): 6055. doi: 10.3390/ijerph18116055
  19. El Seifi OS, Younis FE, Alsaiari NA, Alanazi RM, Alanazi AK, Alamri LM, Albalawi MS, Alatawi SH, Mortada EM. Caffeine intake and awareness of its adverse effects: Insights from the medical students at the University of Tabuk. PLoS One. 2025; 20(10): e0335391. doi: 10.1371/journal.pone.0335391

Submitted date:
05/22/2026

Reviewed date:
06/20/2026

Accepted date:
06/25/2026

Publication date:
06/24/2026

6a3c40eda9539502f81ca992 mjpe Articles
Links & Downloads

Mediterr J Med Res

Share this page
Page Sections